Introduces New Model That Delivers Greater Coding Precision and Automation to Reduce Errors, Accelerate Payments, and Close the Loop Between Care ...

Conflicting studies on GLP-1 drugs’ vision impacts prompt calls for baseline eye exams and monitoring.

Electronic health record (EHR) adoption was driven, in part, by a recognition of the power of data. Given the complexities of healthcare ...

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for CTx-1301 for the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adults.

Flying to popular destinations including Bangkok, Sydney and Singapore and with a reputation for in-flight luxury, it’s no surprise that an Emirates trip will come with a handsome price tag. So that ...

The FDA has expanded the label for oral semaglutide (Rybelsus; Novo Nordisk) tablets 7 mg and 14 mg to reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who ...

Presenters at the AAO discussed phase 2 clinical trial results evaluating the safety and efficacy of foselutoclax (UBX1325) compared with aflibercept in diabetic macular edema.